ABCA1 and prostate carcinoma: Interestingly, aberrant ABCA1 promoter methylation was more prevalent in intermediate- and high-grade cancers than in low-grade cancers, suggesting that downregulation of ABCA1 could play a role in the development and progression of prostate cancer [162].